Press release
🌐 Macro
📊 Neutral
🌍 United States
Opioid Use Disorder Diagnoses Among Insured Patients Rise 32.7% Since 2022
FAIR Health reports a 32.7 percent surge in opioid use disorder diagnoses for commercially insured patients since 2022, offering new state-by-state insights via its updated interactive tracker.
Impact
10/10
💡 Key Takeaways
- National opioid use disorder diagnoses rose 32.7 percent over the four-year period.
- The FAIR Health Opioid Tracker provides updated state-level data for public health analysis.
- Data focuses specifically on the commercially insured population in the United States.
📋 Executive Summary
FAIR Health's latest annual Opioid Tracker reveals a 32.7 percent national increase in opioid use disorder diagnoses among commercially insured patients between 2022 and 2026. The interactive tool provides granular data across state lines, highlighting shifting trends in substance use disorder treatment and prevalence.
📊 Sentiment Analysis
Sentiment
📊 Neutral
Impact Score
10/10
Region
🌍 United States
Asset Class
🌐 Macro
❓ Frequently Asked Questions
The tool tracks the prevalence of opioid use disorder diagnoses among commercially insured patients on both a national and state-by-state basis.
The update reports a 32.7 percent increase in opioid use disorder diagnoses among the commercially insured population from 2022 to 2026.
📰 Source
📅 Originally published:
⚠️ Disclaimer: This content is for training purposes only and should not be considered financial advice. Always conduct your own research before making investment decisions.